Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat...
6 insider purchases on record · latest filing 2017-11-27.
Insiders have also filed 413 sale transactions at GKOS.